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Objective:  56 
Endometriosis—the implantation of endometrial-like tissue outside of the uterus—burdens an 57 
estimated 6-10% of women worldwide and is associated with chronic pelvic pain and 58 
infertility.1,2 Currently, the standard method of diagnosis is surgery, which creates barriers to 59 
care and delays in diagnosis.3 As a result, many questions fundamental to our understanding of 60 
endometriosis remain unanswered. The objective of this work is to identify which research 61 
questions are most meaningful to those personally affected by the disease, as compared to those 62 
treating and studying it.  63 
 64 
Study Design:  65 
In 2016, a James Lind Alliance (JLA) Endometriosis Priority Setting Partnership was formed to 66 
identify endometriosis-related questions of the highest priority in the United Kingdom.4 Research 67 
questions were gathered by online survey using well-established JLA methodology5 68 
complemented by systematic reviews and clinical guidelines. As surveys were completed 69 
anonymously and data were deidentified, this research was exempt from Institutional Review 70 
Board approval. Ultimately, 72 questions were ranked by 1,418 patients, family and friends, and 71 
healthcare practitioners, to generate a final list of ten research priorities.4 Rankings from 339 72 
international respondents were excluded in the initial publication, and included here.  73 
Subsequently, at the 13th World Congress of Endometriosis in 2017, 298 international healthcare 74 
practitioners and scientists ranked the top 72 questions identified previously, via survey.4 The 75 
purpose of this follow-up study was to compare the priorities for respondents personally affected 76 
by endometriosis (patients and close family), with those of clinicians and scientists focusing on 77 
endometriosis.  78 
3 
 
Questions were arranged into ten subject areas (Table). Respondents’ rankings of subject areas 79 
were analyzed according to personal diagnosis of (and/or close family member with) 80 
endometriosis, employment as healthcare provider or scientist, and gender. Multivariable log-81 
binomial regression modeled the relative risk and 95% confidence interval of prioritization of 82 
each subject area, comparing responses from patients/families (referent) to those of healthcare 83 
providers/scientists, adjusting for age (< or >45 years) and gender; respondents fitting into both 84 
groups were excluded from these comparison analyses. In secondary analyses, we compared 85 
male respondents to female (referent) respondents adju ting for respondent type (Patient/family 86 
member, healthcare provider/researcher, or both) and age.   87 
 88 
Results:  89 
Overall (n=2,055), a majority of respondents priorit zed research questions about endometriosis 90 
treatment (84.2%). As compared to patients/family members (n=1,575), healthcare 91 
providers/scientists (n=245) were more likely to prioritize research questions about 92 
cause/pathology or risk factors for endometriosis, diagnosis and screening, treatment, and 93 
fertility (Table). Patients and family members were more likely to prioritize questions about 94 
education/awareness, emotional impact, and comorbid con itions. Priorities of respondents who 95 
were both patients/families and providers/scientists (n=235) were nearly identical to responses of 96 
patients/families (not shown). Male respondents were more likely to prioritize cause/pathology 97 
or risk factors, cure, and fertility, while female respondents prioritized education/awareness, 98 
emotional impact, and alternative therapies, even after djustment for responder category 99 
(patients/families vs. providers/scientists).  100 
 101 
Conclusion:  102 
4 
 
While clinicians and scientists largely dictate research objectives, this study demonstrates that 103 
the priorities of patients and their families differ in a number of key areas, including education 104 
and emotional effects of endometriosis. In the era of patient-centered care, this confirms that 105 
patients’ questions and concerns must be incorporated in o research directions, and currently, 106 
certain needs and interests of endometriosis patients may not be adequately recognized. 107 
 108 
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1 Respondents who were both patients/family members and clinicians or researchers (n=235) were excluded from this analysis. 
2 Log-binomial regression was used to calculate the relative risk of prioritizing each subject area (dependent variable) comparing patient and/or family member with 
endometriosis (referent) to health care provider or researcher   
3 Risk ratios were adjusted for gender and age (<45 vs. >45 years) 
4 Respondents who did not state their gender (n = 8) are excluded from this analysis. 
5 Log-binomial regression was used to calculate the relative risk of prioritizing each subject area (dependent variable) comparing males with females (referent). 
6 Risk ratios were adjusted for respondent type (Patient/family member, health care provider/researcher, or both) and age (<45 vs. >45 years) 
 
